InvestorsHub Logo
Followers 21
Posts 1596
Boards Moderated 1
Alias Born 09/16/2008

Re: None

Wednesday, 08/06/2014 8:30:11 AM

Wednesday, August 06, 2014 8:30:11 AM

Post# of 85
Our international biologics sales increased 21% as the result of a 44% increase of sales in Australia, primarily related to sales of Augment® Bone Graft acquired from the BioMimetic acquisition in the first quarter of 2013, and a 20% increase in Asia as the result of the addition of a new distribution partner in China in the second quarter of 2013.

Source: http://www.sec.gov/Archives/edgar/data/1137861/000113786114000039/wmgi630201410q.htm